Baseline Symptom Score (Safety Analysis Set)
| Baseline number of days with symptoms | ||||||
|---|---|---|---|---|---|---|
| 177Lu-DOTATATE (n = 112) | High-dose octreotide LAR (n = 111) | |||||
| Symptom | <4 d | 4–10 d | >10 d | <4 d | 4–10 d | >10 d |
| Abdominal pain | 50 (44.6) | 12 (10.7) | 25 (22.3) | 45 (40.5) | 13 (11.7) | 26 (23.4) |
| Diarrhea | 31 (27.7) | 14 (12.5) | 42 (37.5) | 35 (31.5) | 21 (18.9) | 28 (25.2) |
| Flushing | 43 (38.4) | 17 (15.2) | 27 (24.1) | 45 (40.5) | 13 (11.7) | 26 (23.4) |
Data are number followed by percentage in parentheses.